Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 92

1.

Perceptions vs. evidence: therapeutic substitutes for antipsychotics in patients with dementia in long-term care.

Olivieri-Mui BL, Devlin JW, Ochoa A, Schenck D, Briesacher B.

Aging Ment Health. 2018 Apr;22(4):544-549. doi: 10.1080/13607863.2016.1277974. Epub 2017 Jan 12.

PMID:
28080146
2.

Screening Tool of Older Person's Prescriptions/Screening Tools to Alert Doctors to Right Treatment Medication Criteria Modified for U.S. Nursing Home Setting.

Khodyakov D, Ochoa A, Olivieri-Mui BL, Bouwmeester C, Zarowitz BJ, Patel M, Ching D, Briesacher B.

J Am Geriatr Soc. 2017 Mar;65(3):586-591. doi: 10.1111/jgs.14689. Epub 2016 Dec 23.

3.

Approaches to Gradual Dose Reduction of Chronic Off-Label Antipsychotics Used for Behavioral and Psychological Symptoms of Dementia.

Tjia J, Reidenberg MM, Hunnicutt JN, Paice K, Donovan JL, Kanaan A, Briesacher BA, Lapane KL.

Consult Pharm. 2015 Oct;30(10):599-611. doi: 10.4140/TCP.n.2015.599. Review.

PMID:
26450142
4.

Dissemination of Evidence-Based Antipsychotic Prescribing Guidelines to Nursing Homes: A Cluster Randomized Trial.

Tjia J, Field T, Mazor K, Lemay CA, Kanaan AO, Donovan JL, Briesacher BA, Peterson D, Pandolfi M, Spenard A, Gurwitz JH.

J Am Geriatr Soc. 2015 Jul;63(7):1289-98. doi: 10.1111/jgs.13488. Epub 2015 Jul 14.

PMID:
26173554
5.

Did Medicare Part D Affect National Trends in Health Outcomes or Hospitalizations? A Time-Series Analysis.

Briesacher BA, Madden JM, Zhang F, Fouayzi H, Ross-Degnan D, Gurwitz JH, Soumerai SB.

Ann Intern Med. 2015 Jun 16;162(12):825-33. doi: 10.7326/M14-0726.

6.

Pain management in nursing home residents with cancer.

Pimentel CB, Briesacher BA, Gurwitz JH, Rosen AB, Pimentel MT, Lapane KL.

J Am Geriatr Soc. 2015 Apr;63(4):633-41. doi: 10.1111/jgs.13345.

7.

Use of atypical antipsychotics in nursing homes and pharmaceutical marketing.

Pimentel CB, Donovan JL, Field TS, Gurwitz JH, Harrold LR, Kanaan AO, Lemay CA, Mazor KM, Tjia J, Briesacher BA.

J Am Geriatr Soc. 2015 Feb;63(2):297-301. doi: 10.1111/jgs.13180.

8.

Antidepressant Use and Cognitive Decline: The Health and Retirement Study.

Saczynski JS, Rosen AB, McCammon RJ, Zivin K, Andrade SE, Langa KM, Vijan S, Pirraglia PA, Briesacher BA.

Am J Med. 2015 Jul;128(7):739-46. doi: 10.1016/j.amjmed.2015.01.007. Epub 2015 Jan 30.

9.

Inappropriate drug use in advanced dementia—reply.

Tjia J, Briesacher BA.

JAMA Intern Med. 2015 Feb;175(2):315-6. doi: 10.1001/jamainternmed.2014.7029. No abstract available.

PMID:
25642675
10.

Use of medications of questionable benefit in advanced dementia.

Tjia J, Briesacher BA, Peterson D, Liu Q, Andrade SE, Mitchell SL.

JAMA Intern Med. 2014 Nov;174(11):1763-71. doi: 10.1001/jamainternmed.2014.4103. Erratum in: JAMA Intern Med. 2014 Dec;174(12):2037.

11.

Persistent medication affordability problems among disabled Medicare beneficiaries after Part D, 2006-2011.

Naci H, Soumerai SB, Ross-Degnan D, Zhang F, Briesacher BA, Gurwitz JH, Madden JM.

Med Care. 2014 Nov;52(11):951-6. doi: 10.1097/MLR.0000000000000205.

12.

Medication affordability gains following Medicare Part D are eroding among elderly with multiple chronic conditions.

Naci H, Soumerai SB, Ross-Degnan D, Zhang F, Briesacher BA, Gurwitz JH, Madden JM.

Health Aff (Millwood). 2014 Aug;33(8):1435-43. doi: 10.1377/hlthaff.2013.1067.

13.

Response to the letter by Mol.

Briesacher BA, Soumerai SB, Zhang F, Toh S, Andrade SE, Wagner JL, Shoaibi A, Gurwitz JH.

Pharmacoepidemiol Drug Saf. 2014 Jan;23(1):106. doi: 10.1002/pds.3519. No abstract available.

PMID:
24395548
14.

Antipsychotic use in nursing homes varies by psychiatric consultant.

Tjia J, Field T, Lemay C, Mazor K, Pandolfi M, Spenard A, Ho SY, Kanaan A, Donovan J, Gurwitz JH, Briesacher B.

Med Care. 2014 Mar;52(3):267-71. doi: 10.1097/MLR.0000000000000076.

15.

Knowledge of and perceived need for evidence-based education about antipsychotic medications among nursing home leadership and staff.

Lemay CA, Mazor KM, Field TS, Donovan J, Kanaan A, Briesacher BA, Foy S, Harrold LR, Gurwitz JH, Tjia J.

J Am Med Dir Assoc. 2013 Dec;14(12):895-900. doi: 10.1016/j.jamda.2013.08.009. Epub 2013 Sep 24.

PMID:
24074962
16.

Dr. Harrold, et al reply.

Harrold LR, Gurwitz JH, Briesacher BA.

J Rheumatol. 2013 Aug;40(8):1462. No abstract available.

17.

Reported racial discrimination, trust in physicians, and medication adherence among inner-city African Americans with hypertension.

Cuffee YL, Hargraves JL, Rosal M, Briesacher BA, Schoenthaler A, Person S, Hullett S, Allison J.

Am J Public Health. 2013 Nov;103(11):e55-62. doi: 10.2105/AJPH.2013.301554. Epub 2013 Sep 12.

18.

A critical review of methods to evaluate the impact of FDA regulatory actions.

Briesacher BA, Soumerai SB, Zhang F, Toh S, Andrade SE, Wagner JL, Shoaibi A, Gurwitz JH.

Pharmacoepidemiol Drug Saf. 2013 Sep;22(9):986-94. doi: 10.1002/pds.3480. Epub 2013 Jul 12. Review.

19.

Medicare part D and long-term care: a systematic review of quantitative and qualitative evidence.

Pimentel CB, Lapane KL, Briesacher BA.

Drugs Aging. 2013 Sep;30(9):701-20. doi: 10.1007/s40266-013-0096-6. Review.

PMID:
23729166
20.

Studies to reduce unnecessary medication use in frail older adults: a systematic review.

Tjia J, Velten SJ, Parsons C, Valluri S, Briesacher BA.

Drugs Aging. 2013 May;30(5):285-307. doi: 10.1007/s40266-013-0064-1. Review.

PMID:
23475597

Supplemental Content

Loading ...
Support Center